KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Non-Current Assets (2017 - 2025)

Historic Non-Current Assets for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $30.7 million.

  • Co-Diagnostics' Non-Current Assets fell 493.28% to $30.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.9 million, marking a year-over-year decrease of 461.5%. This contributed to the annual value of $31.7 million for FY2024, which is 443.45% down from last year.
  • Per Co-Diagnostics' latest filing, its Non-Current Assets stood at $30.7 million for Q3 2025, which was down 493.28% from $31.2 million recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' Non-Current Assets registered a high of $46.3 million during Q2 2022, and its lowest value of $2.0 million during Q1 2021.
  • For the 5-year period, Co-Diagnostics' Non-Current Assets averaged around $30.5 million, with its median value being $32.3 million (2024).
  • The largest annual percentage gain for Co-Diagnostics' Non-Current Assets in the last 5 years was 220869.02% (2022), contrasted with its biggest fall of 3242.21% (2022).
  • Co-Diagnostics' Non-Current Assets (Quarter) stood at $44.9 million in 2021, then plummeted by 32.42% to $30.4 million in 2022, then increased by 9.31% to $33.2 million in 2023, then decreased by 4.43% to $31.7 million in 2024, then decreased by 3.22% to $30.7 million in 2025.
  • Its Non-Current Assets stands at $30.7 million for Q3 2025, versus $31.2 million for Q2 2025 and $31.3 million for Q1 2025.